Supplement Product

ZMA

mineralproduct

A zinc–magnesium–B6 formula marketed for recovery, sleep and testosterone — the individual nutrients are well established, but ZMA's specific performance claims are weakly supported.

Ingredients (3)

What ZMA Is

ZMA is a fixed-ratio zinc–magnesium–vitamin B6 formula, originally patented and marketed to athletes for recovery, sleep quality and testosterone support. It is a product, not a molecule — everything ZMA does it does through the three nutrients in it, so each ingredient links to its own monograph, where that nutrient’s full evidence lives.

The combination is not arbitrary. Zinc and magnesium are minerals that hard-training athletes lose in sweat and can run marginal on, and vitamin B6 is a cofactor in the metabolism of both. As a bet on deficiency being common in that population, the formula is reasonable.

What it is not is a compound with its own pharmacology — which is why the honest evaluation is ingredient by ingredient, and why the interesting question is whether the combination, at these doses, does anything beyond correcting a shortfall.

What the Evidence Says

The three ingredients are individually well characterised on their own pages: magnesium has modest human evidence for blood pressure, glycemic markers and migraine (and popular but thin sleep data); zinc is genuinely useful in deficiency and for immunity; vitamin B6 is a cofactor whose supplemental benefit is greatest when dietary intake is low. That is the ingredient-level picture, and it is not re-litigated here.

ZMA’s own selling point — that this specific formula raises testosterone and boosts performance — is the weakest part, and it has been tested directly.

The frequently cited positive result is an industry-linked study in NCAA football players reported to be low in zinc and magnesium, which found increases in testosterone and strength 1Reference 1Brilla LR · 2000RCTEffects of a novel zinc-magnesium formulation on hormones and strength — RCT, industry-linkedView study →. It is worth knowing that this study is not PubMed-indexed and was industry-linked — it does not carry the same evidentiary weight as the independent trials that followed.

Those independent trials, in people with adequate mineral status, have not reproduced it:

  • A double-blind trial designed specifically to test the advertising claim gave ZMA to zinc-sufficient exercising men (baseline zinc intake 11.9–23.2 mg/day). Serum and urinary zinc rose, but there was no significant change in total or free testosterone and no shift in steroid-metabolite excretion 2Reference 2Koehler K et al. · 2009RCTSerum testosterone and urinary excretion of steroid hormone metabolites after administration of a high-dose zinc supplement — double-blind randomised controlled trialView study →.
  • An 8-week double-blind trial in 42 resistance-trained men found ZMA raised serum zinc only non-significantly (11–17%, p=0.12) and produced no difference versus placebo in anabolic or catabolic hormones, 1-RM bench or leg press, muscular endurance, anaerobic power, or body composition 3Reference 3Wilborn CD et al. · 2004RCTEffects of zinc magnesium aspartate (ZMA) supplementation on training adaptations and markers of anabolism and catabolism — double-blind randomised controlled trialView study →.
  • A 2024 crossover trial in recreationally trained males with adequate micronutrient intake found an acute ZMA dose had no effect on objective sleep, repeated-sprint performance or cognition versus placebo 4Reference 4Edwards BJ et al. · 2024RCTEffects of an acute dose of zinc monomethionine aspartate and magnesium aspartate (ZMA) on subsequent sleep and next-day morning performance — randomised crossover trialView study → — closing the loop on the sleep claim, not just the testosterone one.

The most defensible read is that ZMA works mainly by correcting a zinc or magnesium deficiency — where zinc repletion demonstrably restores testosterone in men who were marginally deficient 5Reference 5Prasad AS et al. · 1996ObservationalZinc status and serum testosterone levels of healthy adults — interventional/cross-sectional studyView study → — and not as an ergogenic aid in well-nourished users.

That pattern, a real effect in deficient populations that fails to generalise to replete ones, is the same one that shows up on the zinc page for testosterone claims generally. It is not a knock on the ingredients; it is a statement about who benefits. For an athlete with a genuine mineral shortfall, ZMA is a plausible, cheap correction. For a replete athlete chasing higher testosterone or performance, the controlled evidence is consistently null.

Last checked: August 2026.

Dosage

One serving before bed — the standard patented formula supplies zinc 30 mg (as monomethionine/aspartate), magnesium 450 mg (as aspartate) and vitamin B6 ~10.5 mg — taken away from calcium-rich food, which can blunt mineral absorption. These are label and study figures, not a personal recommendation.

Three practical notes. The bedtime timing comes from the sleep-and-recovery positioning, not from any absorption argument — and the one trial to test it directly found no sleep effect 4Reference 4Edwards BJ et al. · 2024RCTEffects of an acute dose of zinc monomethionine aspartate and magnesium aspartate (ZMA) on subsequent sleep and next-day morning performance — randomised crossover trialView study →. The zinc dose is the number to check against everything else you take: multivitamins, other mineral products and fortified foods all stack, and 30 mg from a single product already leaves very little headroom under the upper limit. And for minerals generally, fractional absorption falls as the dose rises, so a large single bolus is absorbed less efficiently than the label weight implies.

Safety

The main caution is zinc. At 30 mg/day from the supplement, added to ordinary dietary zinc, total intake runs past the 40 mg/day tolerable upper limit, and prolonged high zinc intake causes copper deficiency — zinc and copper compete for absorption, and that competition is the mechanism behind the UL. ZMA is therefore best used short-term, or with attention to copper status, rather than indefinitely.

Interactions. The minerals in ZMA slow the absorption of, and are slowed by, several drug classes: separate ZMA from bisphosphonates, tetracycline and quinolone (fluoroquinolone) antibiotics by several hours. Magnesium and zinc can also reduce absorption of some thyroid medication if taken at the same time.

Who should be cautious. People with kidney impairment should not self-supplement magnesium — reduced renal clearance raises the risk of hypermagnesemia, so this is a decision for a clinician, not a label.

Scope disclosure. Interactions were assessed: mineral–drug absorption interactions (bisphosphonates, tetracycline and quinolone antibiotics, thyroid medication) and zinc–copper antagonism. Pregnancy and lactation were assessed — the formula’s dosing, not the nutrients, is the issue. An Upper Limit exists for the components rather than the product: zinc’s 40 mg/day for adults, which ZMA’s 30 mg plus diet routinely exceeds. Absence of a reported harm is not evidence of safety; the product-level risk here is well characterised, and it is the zinc load.

Safety at a Glance
Low / no toxicitySlows drug absorption
  • The zinc dose leaves no headroom. 30 mg plus diet exceeds the 40 mg/day upper limit; stacking another zinc-containing product compounds it.
  • Copper depletion with prolonged use. Zinc and copper compete for absorption — this is the mechanism behind the upper limit.
  • Mineral–drug absorption interactions. Separate from bisphosphonates, tetracycline and quinolone antibiotics, and from thyroid medication.
  • Kidney impairment. Supplemental magnesium is not a self-directed decision where renal clearance is reduced.
  • Best used short-term rather than indefinitely without monitoring.
Pregnancy & Lactation
Caution in pregnancy Caution while breastfeeding

Caution — the individual nutrients are fine at prenatal doses; this formula is not a prenatal dose. Zinc, magnesium and vitamin B6 all have established roles in pregnancy at reference-intake levels, and B6 is used clinically for nausea. ZMA supplies roughly three times the prenatal zinc RDA, which takes it past the upper limit rather than toward the requirement. Use prenatal-appropriate dosing under clinical guidance rather than a performance formula.

  • Ingredient monographs: Zinc · Magnesium · Vitamin B6
  • Related: the zinc page’s testosterone section shows the same deficiency-versus-repletion pattern.

References

  1. Brilla LR, Conte V (2000). Effects of a novel zinc-magnesium formulation on hormones and strength — RCT, industry-linked. Journal of Exercise Physiology Online. Not PubMed-indexed; cited descriptively as the frequently referenced positive study. https://www.asep.org/asep/asep/BrillaV2.PDF
  2. Koehler K, Parr MK, Geyer H, Mester J, Schänzer W (2009). Serum testosterone and urinary excretion of steroid hormone metabolites after administration of a high-dose zinc supplement — double-blind randomised controlled trial. European Journal of Clinical Nutrition. https://pubmed.ncbi.nlm.nih.gov/17882141/
  3. Wilborn CD, Kerksick CM, Campbell BI, et al. (2004). Effects of zinc magnesium aspartate (ZMA) supplementation on training adaptations and markers of anabolism and catabolism — double-blind randomised controlled trial. Journal of the International Society of Sports Nutrition. https://pubmed.ncbi.nlm.nih.gov/18500945/
  4. Edwards BJ, Adam RL, Drummond D, et al. (2024). Effects of an acute dose of zinc monomethionine aspartate and magnesium aspartate (ZMA) on subsequent sleep and next-day morning performance — randomised crossover trial. Nutrients. https://pubmed.ncbi.nlm.nih.gov/39125347/
  5. Prasad AS, Mantzoros CS, Beck FW, Hess JW, Brewer GJ (1996). Zinc status and serum testosterone levels of healthy adults — interventional/cross-sectional study. Nutrition. https://pubmed.ncbi.nlm.nih.gov/8875519/

From the Journal

View all articles →